Skip to main content

Table 3 Renal function and metabolic effects

From: An exploratory study with an adaptive continuous intravenous furosemide regimen in neonates treated with extracorporeal membrane oxygenation

 

Start of ECMO

0 hours

24 hours

48 hours

72 hours

Renal function

     

   ◦ Creatinine (μmol/l)

35 (19–106)

29.5 (19–106)

40.5 1(6–131)

44 (22–112)

23 (20–41)

   ◦ BUN (mmol/l)

2.05 (1.1–3.8)

2.2 (1.1–3.8)

3.7 (0.9–8)

6 (0.9–7.1)

2.1 (1.5–6)

   ◦ Albumin (g/l)

24 (19–27)

26 (23–35)

28 (25–34)

28 (25–31)

29 (27–29)

Acid-base balance

     

   ◦ pH

7.3 (6.97–7.47)

7.4 (7.24–7.47)

7.42 (7.38–7.48)

7.48 (7.43–7.6)

7.47 (7.45–7.67)

   ◦ Bicarbonate level (mmol/l)

22.2 (17.4–33.5)

24.2 (17.4–33.5)

29.8 (23.4–35.2)

31.8 (23.8–35.1)

33.9 (26.3–36.5)

   ◦ Base excess

-4 (-12 to 9)

1 (-9 to 9)

5 (-1 to 10)

7 (1–10)

8 (3–14)

Serum electrolytes

     

   ◦ Sodium (mmol/l)

140 (138–147)

142 (136–147)

136 (132–142)

135 (133–143)

134 (132–141)

   ◦ Potassium (mmol/l)

3.3 (3.1–4.1)

3.3 (2.8–5.4)

3.85 (3.2–6.2)

3.6 (3.1–4.1)

3.9 (3.5–5.7)

   ◦ Chloride (mmol/l)

106.5 (104–109)

104 (104–104)

102 (100–112)

95 (92–98)

99 (95–107)

  1. Data presented as the median (range). ECMO, extracorporeal membrane oxygenation.